Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerry L LaPlante

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Diagnostic Microbiology and Infectious Disease|December 5, 2006
In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureusKerry L LaPlante
Antimicrobial Agents and Chemotherapy|July 1, 2009
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditisKerry L LaPlante, Suzanne Woodmansee
Antimicrobial Agents and Chemotherapy|July 22, 2009
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic modelKerry L LaPlante, George Sakoulas
Rhode Island Medical Journal (2013)|June 3, 2018
Communicating with Facility Leadership; Metrics for Successful Antimicrobial Stewardship Programs (Asp) in Acute Care and Long-Term Care FacilitiesMaya Beganovic, Kerry L LaPlante
Diagnostic Microbiology and Infectious Disease|August 24, 2010
In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureusKevin W McConeghy, Kerry L LaPlante
Expert Opinion on Pharmacotherapy|October 27, 2004
Daptomycin - a novel antibiotic against Gram-positive pathogensKerry L LaPlante, Michael J Rybak
Pharmacotherapy|March 16, 2005
Community-associated methicillin-resistant Staphylococcus aureus: a reviewMichael J Rybak, Kerry L LaPlante
Diagnostic Microbiology and Infectious Disease|October 12, 2004
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecyclineKerry L LaPlante, Michael J Rybak
Antimicrobial Agents and Chemotherapy|September 16, 2015
Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic ModelMegan K Luther, Kerry L LaPlante
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 4, 2007
In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter modelKerry L LaPlante, Leonard A Mermel
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Diagnostic Microbiology and Infectious Disease|December 5, 2006
In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureusKerry L LaPlante
Antimicrobial Agents and Chemotherapy|July 1, 2009
Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditisKerry L LaPlante, Suzanne Woodmansee
Antimicrobial Agents and Chemotherapy|July 22, 2009
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic modelKerry L LaPlante, George Sakoulas
Rhode Island Medical Journal (2013)|June 3, 2018
Communicating with Facility Leadership; Metrics for Successful Antimicrobial Stewardship Programs (Asp) in Acute Care and Long-Term Care FacilitiesMaya Beganovic, Kerry L LaPlante
Diagnostic Microbiology and Infectious Disease|August 24, 2010
In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureusKevin W McConeghy, Kerry L LaPlante
Expert Opinion on Pharmacotherapy|October 27, 2004
Daptomycin - a novel antibiotic against Gram-positive pathogensKerry L LaPlante, Michael J Rybak
Pharmacotherapy|March 16, 2005
Community-associated methicillin-resistant Staphylococcus aureus: a reviewMichael J Rybak, Kerry L LaPlante
Diagnostic Microbiology and Infectious Disease|October 12, 2004
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecyclineKerry L LaPlante, Michael J Rybak
Antimicrobial Agents and Chemotherapy|September 16, 2015
Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic ModelMegan K Luther, Kerry L LaPlante
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 4, 2007
In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter modelKerry L LaPlante, Leonard A Mermel
Pageof 12